PUBLISHED IN THE OFFICIAL JOURNAL OF THE PATENT OFFICE DATED – 25/11/2011-PART I Sr. Application No. Title of the Invention Date of Applicant No. Application 1. 3232/CHE/2011 An Animal Feed Supplement For 20/09/2011 Gundareddy Amareswara Bird Immunization By Organic Rao Supplements 2. 5844/DELNP/2010 Treatment And Prevention Of 17/08/2010 Viromed Co., Ltd Cardiac Conditions Using Two Or More Isoforms Of Hepatocyte Growth Factor 3. 5866/DELNP/2010 Solid Forms Of Ortataxel 18/08/2010 Indena S.P.A. 4. 2844/DEL/2010 Solid Acid Catalyst And Method 30/11/2010 Jiangsu Sinorgchem For Preparing And Using The Same Technology Co., Ltd 5. 5847/DELNP/2010 Protease Stabilized, Acylated 17/08/2010 Novo Nordisk A/S Insulin Analogues 6. 5848/DELNP/2010 New Brassica Ogura Restorer Lines 17/08/2010 Pioneer Hi-Bred With Shotened Raphanus Fragment International, Inc. (SRF) 7. 5850/DELNP/2010 Cross-Neutralizing Human 17/08/2010 Humab, Llc Monoclonal Antibodies To Sars-Co V And Methods Of Use Thereof 8. 5907/DELNP/2010 Substituted Piperidines As 19/08/2010 Novartis Ag Therapeutic Compounds 9. 6093/DELNP/2010 Modified Release Composition 27/08/2010 Eurodrug Laboratories B.V. Comprising Doxofylline 10. 6085/DELNP/2010 Oxadiazoanthracene Compounds 27/08/2010 Transtech Pharma, Inc. For The Treatment Of Diabetes 11. 6102/DELNP/2010 Polypeptides And Polynucleotides, 27/08/2010 Compugen Ltd And Uses Thereof As A Drug Target For Producing Drugs And Biologics 12. 6115/DELNP/2010 Substituted 4-Hydroxypyrimidine- 27/08/2010 Merck Sharp & Dohme 5-Carboxamides Corp. 13. 6128/DELNP/2010 Microna (Mirna) And Downstream 30/08/2010 Julius Maximilians- Targets For Diagnostic And Universitat Wurzburg Therapeutic Purposes 14. 6136/DELNP/2010 Proteins Ezrin, Serpin B5, 30/08/2010 Ludwig-Maximilians- Peroxiredoxin-2 And Heat Shock Universitat Protein Beta-1 As Autoantigens For Psoriasis Vulgaris And Poststreptococcal Diseases 15. 6140/DELNP/2010 Process For The Preparation Of 2- 30/08/2010 Novartis Ag Amino-2 [2-(4-C3-C21-Alkyl- Phenyl)Ethyl]Propane-1, 3-Diols 1 Gopakumar Nair Associates 16. 6090/DELNP/2010 Stabilized Angiopoietin-2 27/08/2010 Medimmune Limited Antibodies And Uses Thereof 17. 6161/DELNP/2010 Pesticides 31/08/2010 Dow Agrosciences LLC 18. 6174/DELNP/2010 Short Fatty Acid Tail Polymyxin 31/08/2010 Northern Antibiotics Oy Derivatives And Uses Thereof 19. 6156/DELNP/2010 Pharmaceutical Solutions, Process 31/08/2010 UCB Pharma, S.A. Of Preparation And Therapeutic Uses 20. 6202/DELNP/2010 Combined Use Of Cholestanol 01/09/2010 Otsuka Pharmaceutical Co., Derivative Ltd. 21. 6179/DELNP/2010 A Process For Preparing 31/08/2010 Huntsman International Polyisocyanates LLC. 22. 6249/DELNP/2010 Substituted Cyclopentanes Having 03/09/2010 Allergan Inc Prostaglandin Activity 23. 6252/DELNP/2010 Crystalline Forms And Two 03/09/2010 Novartis Ag Solvated Forms Of 4-Amino-5- Fluoro-3-[5-(4-Methylpiperazin- 1- Yl)-1h-Benzimidazol-2-Yl] Quinolin-2(1H)-One Lactic Acid Salts 24. 6217/DELNP/2010 Heterocyclic Inhibitors Of Stearoyl- 01/09/2010 Novartis Ag Coa Desaturase 25. 6218/DELNP/2010 Use Of Virus-Induced Gene 01/09/2010 Pioneer Hi-Bred Silencing (Vigs) To Down- International, Inc. Regulate Genes In Plants 26. 6276/DELNP/2010 Tricyclic Pyridine Derivatives, 06/09/2010 Boehringer Ingelheim Medicaments Containing Such International GMBH Compounds, Their Use And Process For Their Preparation 27. 6267/DELNP/2010 Novel Androgenic Gland Hormone 03/09/2010 Vib Vzw 28. 6294/DELNP/2010 Processes For The Preparation Of 06/09/2010 Arena Pharmaceuticals, Inc. Intermediates Related To The 5- HT2C Agonist (R)-8-Chloro-1- Methyl-2,3,4,5-Tetrahydro-1h-3- Benzazepine 29. 6295/DELNP/2010 Therapeutic Peptidomimetic 06/09/2010 Aileron Therapeutics Inc. Macrocycles 30. 6296/DELNP/2010 Bioconjugates Made From 06/09/2010 Glycovaxyn Ag Recombinant N-Glycosylated Proteins From Procaryotic Cells 31. 6300/DELNP/2010 Monoclonal Antibodies For Tumor 06/09/2010 Curetech Ltd. Treatment 32. 6302/DELNP/2010 Pharmaceutical Composition 06/09/2010 Takeda Pharmaceutical Company Limited 33. 6303/DELNP/2010 Filamentous Fungi With Inactivated 06/09/2010 Danisco Us Inc., Genecor Protease Genes For Altered Protein Division Production 34. 6305/DELNP/2010 Thermoplastic Starch Compounds 06/09/2010 Swiss Caps Rechte Und Lizenzen Ag 2 Gopakumar Nair Associates 35. 6297/DELNP/2010 Polymer Paclitaxel Conjugates And 06/09/2010 Nitto Denko Corporation Methods For Treating Cancer 36. 6298/DELNP/2010 Selected Antibodies Binding To 06/09/2010 Board Of Regents, The Anionic Phospholipids & University Of Texas System Aminophospholipids And Their Use In Treating Viral Infections And Cancer 37. 6310/DELNP/2010 Compound 07/09/2010 Sterix Limited 38. 6313/DELNP/2010 Azeotrope-Like Composition Of 07/09/2010 Arkema, Inc. 1,1,1-Trifluoro-3-Chloropropene And Methyl Acetate 39. 6314/DELNP/2010 Azeotrope-Like Composition Of 07/09/2010 Arkema, Inc. 1,1,1-Trifluoro-3-Chloropropene And Dimethoxymethane 40. 6318/DELNP/2010 Compositions And Methods For 07/09/2010 Baxter International Inc. Drug Delivery 41. 6306/DELNP/2010 Medium Chain Dicarboxylic Acids, 06/09/2010 Nestec S.A. Their Derivates And Metabolic Disorders 42. 6309/DELNP/2010 Azeotrope-Like Composition Of 07/09/2010 Arkema, Inc. 1,1,1-Trifluoro-3-Chloropropene And Trans-1,2- Dichloroethylene 43. 6320/DELNP/2010 Disease Markers And Uses Thereof 07/09/2010 Medimmune, LLC 44. 6319/DELNP/2010 Anti-Ifnari Antibodies With 07/09/2010 Medimmune, LLC., Reduced FC Ligand Affinity 45. 6332/DELNP/2010 Process For Preparing An 07/09/2010 Euro-Celtique S.A. Oxycodone Hydrochloride Composition Having Less Than 25 PPM 14-Hydroxycodeinone 46. 6335/DELNP/2010 Use Of Sirna To Achieve Down 07/09/2010 Senesco Technologies, Inc. Regulation Of An Endogenous Gene In Combination With The Use Of A Sense Construct To Achieve Expression Of A Desired Polynucleotide 47. 6323/DELNP/2010 Quinoline Derivatives As AXL 07/09/2010 Max-Planck-Gesellschaft Kinase Inhibitors Zur Forderung Der Wissenschaften E.V. 48. 6935/DELNP/2010 Antigen-And-Drug Vehicle 01/10/2010 The University Of Comprising Synthetic Peptide, And Tokushima Mucosal Vaccine Using The Same 49. 6943/DELNP/2010 DPP-IV Inhibitor Combined With 01/10/2010 Boehringer Ingelheim A Further Antidiabetic Agent, International Gmbh Tablets Comprising Such Formulations, Their Use And Process For Their Preparation 50. 6985/DELNP/2010 Triazolopyridinone Derivatives For 01/10/2010 Gilead Sciences, Inc. Use As Stearoyl Coa Desaturase Inhibitors 3 Gopakumar Nair Associates 51. 6988/DELNP/2010 Methods Of Treatment Using Anti- 01/10/2010 Carolus Therapeutics, Inc. MIF Antibodies 52. 7057/DELNP/2010 Novel Sirna Compounds For 06/10/2010 Quark Pharmaceuticals, Inc. Inhibiting RTP801 53. 7063/DELNP/2010 Double-Stranded Lipid-Modified 06/10/2010 National Institute Of RNA Having High RNA Advanced Industrial Interference Effect Science And Technology 54. 6980/DELNP/2010 Process For Continuous 01/10/2010 Centre National De La Oligomerization Of Isocyanates Recherche Scientifique (C.N.R.S.) 55. 1170/MUMNP/2010 Personal Care Composition 03/06/2010 Hindustan Unilever Limited 56. 1171/MUMNP/2010 Personal Care Composition 03/06/2010 Hindustan Unilever Limited 57. 1176/MUMNP/2010 Self - Tanning Effects 03/06/2010 Hindustan Unilever Limited 58. 1903/MUMNP/2010 Hair Conditioning Composition 09/09/2010 Hindustan Unilever Limited 59. 1904/MUMNP/2010 Make-Up Removal Composition 09/09/2010 Hindustan Unilever Limited Which Provides Good Foam 60. 1905/MUMNP/2010 Modification Of Particulate- 09/09/2010 Hindustan Unilever Limited Stabilised Fluid-Fluid Interfaces 61. 1907/MUMNP/2010 Conditioning Shampoo 09/09/2010 Hindustan Unilever Limited Composition 62. 1427/MUMNP/2010 Granules 02/07/2010 Hindustan Unilever Limited 63. 1753/MUMNP/2010 Cationic Copolymers Formulated 18/08/2010 Hindustan Unilever Limited With Pigmented Cosmetic Compositions Exhibiting Radiance With Soft Focus 64. 102/CHENP/2006 Orally Dosed Pharmaceutical 09/01/2006 Novartis Ag Compositions Comprising A Delivery Agent In Micronized Form 65. 145/CHENP/2006 Use Of 2,2-Dimethyl-3-(2,4- 12/01/2006 Bayer Cropscience Dichlorophenyl)-2-Oxo-1- Aktiengesellschaft Oxaspiro[4.5]Dec-3-En-4-Yl Butanoate For Controlling Acarids 66. 17/CHE/2009 Novel Crystalline Form Of 05/01/2009 Shodhana Laboratories Citalopram Intermediate Limited 67. 17/CHENP/2006 Arylamine-Substituted 02/01/2006 F. Hoffmann-La Roche Ag Quinazolinone Compounds 68. 17/CHENP/2011 Mixtures Of Amines Having 04/01/2011 Basf Se Guanidine Derivatives_ 69. 177/CHENP/2009 Process For Pure Irbesartan 09/01/2009 M/S Hetero Drugs Limited 70. 189/CHENP/2011 Glycosylated GLP-1 Peptide 11/01/2011 Otsuka Chemical Co., Ltd. 71. 1899/CHENP/2009 Arylphenoxy Catalyst System For 06/04/2009 SK Innovation Co., Ltd Producing Ethylene Homopolymer Or Copolymers Of Ethylene And A-Olefins 4 Gopakumar Nair Associates 72. 2150/CHE/2009 Picrorhiza Kurroa Extract For 04/09/2009 Munisekhar Medasani Prevention, Elimination And Treatment Of RNA Viruses And Infection Or Diseases Caused By The Same In Humans, Animals And Biotech Industry 73. 2149/CHE/2009 Method Of Treatment Of 04/09/2009 Munisekhar Medasani Neurodegenerative Or Neuro- Muscular Degenerative Diseases And Therapeutic Agent To Treat The Same 74. 220/CHE/2009 Enzymatic Process For The 30/01/2009 Matrix Laboratories Ltd Preparation Of Eslicarbazepine Acetate 75. 224/CHE/2009 Composition From Sphaeranthus 02/02/2009 Gokaraju, Ganga Raju Indicus And Garcinia Mangostana For The Control Of Metabolic Syndrome 76. 2873/CHE/2008 Novel Citrate Salt Of Carbapenem 20/11/2008 Orchid Chemicals & Antibiotic Pharmaceuticals Ltd 77. 230/CHE/2009 A Process To Enhance Ethanol 02/02/2009 Richcore Life Sciences Pvt. Yield From Molasses Fermentation, Ltd By Addition Of Enzymes Which Convert Unfer Mentable Sugars Into Fermentable Sugars 78. 2653/CHE/2009 An Improved Process For The 03/11/2009 Actavis Group PTC EHF Preparation Of Posaconazole 79.